Is Drospinenone + Ethinylestradiol registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 4 valid registrations of Drospinenone + Ethinylestradiol, including Diva (3,0.03 mg,mg, Film-coated tablet, SAR 16.35); MIDIANA 3 mg/ 0.3 mg F.C.tablet (3,0.03 mg,mg, Film-coated tablet, SAR 20.20); YASMIN TAB. (3,0.03 mg,mg, Film-coated tablet, SAR 23.75); ZAHRA TABLET (3,0.03 mg,mg, Tablet, SAR 18.15).

Active substances

Drospinenone + Ethinylestradiol

SFDA 4

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
Diva	3,0.03 mg,mg	Film-coated tablet · Oral use	28 Blister	SAR 16.35	Generic · Prescription	Exeltis Healthcare S.L	Valid
MIDIANA 3 mg/ 0.3 mg F.C.tablet	3,0.03 mg,mg	Film-coated tablet · Oral use	21 Blister	SAR 20.20	Generic · Prescription	AJA PHARMACEUTICAL INDUSTRIES	Valid
YASMIN TAB.	3,0.03 mg,mg	Film-coated tablet · Oral use	21 Blister	SAR 23.75	NCE · Prescription	BAYER AG	Valid
ZAHRA TABLET	3,0.03 mg,mg	Tablet · Oral use	21 Blister	SAR 18.15	Generic · Prescription	OMAN PHARMACEUTICAL PRODUCTS	Valid

Indications — CHI Daman Drug Formulary

CONTRACEPTION; ENDOMETRIOSIS; HYPERPROLACTINEMIA; MENOPAUSE; MENSTRUAL DISORDERS

Components

Ethinylestradiol

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.